Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05710029 · ClinicalTrials.gov registry record
Cortical Processes During Walking Post-stroke
A clinical trial of Stroke, Acute and Walking, Difficulty, sponsored by University of Florida.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05710029: Completed study of Stroke, Acute and Walking, Difficulty, sponsored by University of Florida.
NCT05710029 is a study of Stroke, Acute and Walking, Difficulty that has completed, run by University of Florida. The registered enrollment target is 30 participants, below the 629-participant average among 25 other Stroke, Acute trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05710029, a study of Stroke, Acute and Walking, Difficulty, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to use novel mobile imaging techniques with high-density electroencephalography (EEG) to quantify cortical processes synchronized to the biomechanics of walking. Here, the study has two aims - the primary aim is to quantify the cortical processes that contribute to gait dysfunction early post-stroke, and the second aim is to determine how cortical processes are mediated by mechanical assistance during early gait training post-stroke. Participants will wear an electroencephalography (EEG) cap to measure brain activity and other non-invasive physiological sensors. Participants will be asked to perform different tasks, such as walking at different speeds and walking with different levels of body weight support.
Primary Outcome
Changes in brain activity during walking with different levels of weight support
Conditions Studied
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2024-06-30 |
What the finished NCT05710029 record still lists
NCT05710029 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 629-participant average among 25 other Stroke, Acute trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Stroke, Acute appearing as the primary indexed condition, and to 0 interventions.
NCT05710029 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05710029 about?
NCT05710029 is a clinical study titled "Cortical Processes During Walking Post-stroke". The study aims to use novel mobile imaging techniques with high-density electroencephalography (EEG) to quantify cortical processes synchronized to the biomechanics of walking. Here, the study has two aims - the primary aim is to quantify the cortical processes that contribute to gait dysfunction ea...
What is the current status of trial NCT05710029?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2023-05-01. Estimated completion is 2024-06-30.
What conditions does trial NCT05710029 study?
This clinical trial studies the following conditions: Stroke, Acute, Walking, Difficulty.
Who is sponsoring clinical trial NCT05710029?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05710029 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05710029's enrollment target sits among peer trials
30 24th of 25 higher than 1 of 25 other Stroke, Acute trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke, Acute trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Somatic Dysfunction in Patients With Acute Cerebrovascular Disease
RECRUITING
-
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
RECRUITING · NA
-
Focused Intensive Repeated Stepping During Inpatient Rehabilitation Poststroke - A Quality Improvement Project
RECRUITING
-
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
RECRUITING · NA
-
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
RECRUITING · NA
-
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI